NBO Pharma Inc. research brief
CIK 2103906
Generated Nov. 18, 2026, 4:30 a.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.
Current stored business address: BEDFORD New York. Reported legal jurisdiction: DELAWARE. These do not establish investor residence or where funds were deployed.
- Nov. 9, 2026 · D · 0002103906-26-000002 · Source evidence
Reported offering amount: 7000000 USD. Reported amount sold: 238000 USD.
- Jan. 22, 2026 · D · 0002103906-26-000001 · Source evidence
Reported offering amount: 7640217 USD. Reported amount sold: 7640217 USD.
Reviewed offering links
- No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.
Citation: Form D Explorer, “NBO Pharma Inc. research brief,” CIK 2103906, retrieved Nov. 18, 2026, 4:30 a.m.. Cite the specific accessions used. No amounts have been summed.